Interventions for Tuberculosis Control and Elimination 2002

199. Burke M, Logan J. Hepatic dysfunction in tuberculous patients treated with
rifampicin and isoniazid. J Irish Medical Ass 1979; 72: 430-4.
200. Schaberg T, Rebhan K, Lode H. Risk factors for side-effects of isoniazid, rifampin
and pyrazinamide in patients hospitalized for pulmonary tuberculosis.
1996; 9: 2026-30.
Eur Respir J
201. Bistritzer T, Barzilay Z, Jonas A. Isoniazid-rifampin-induced fulminant liver disease
in an infant. J Pediatr 1980; 97: 480-2.
202. Tsagaropoulou-Stinga H, Mataki-Emmanouilidou T, Karida-Kavalioti S, Manios S.
Hepatotoxic reactions in children with severe tuberculosis treated with isoniazidrifampin.
Pediatr Infect Dis 1985; 4: 270-3.
203. Van Aalderen WM, Knoester H, Knol K. Fulminant hepatitis during treatment
with rifampicin, pyrazinamide and ethambutol. Eur J Pediatr 1987; 146: 290-1.
204. Ozick LA, Jacob L, Comer GM, Lee TP, Ben-Zvi J, Donelson SS, Felton CP.
Hepatotoxicity from isoniazid and rifampin in inner-city AIDS patients.
Gastroenterol 1995; 90: 1978-80.
Am J
205. de A Nishioka S. Antituberculosis drugs and hepatotoxicity. (Correspondence).
Am J Gastroenterol 1996; 91: 1471.
206. Ungo JR, Jones D, Ashkin D, Hollender ES, Bernstein D, Albanese AP,
Pitchenik AE. Antituberculosis drug-induced hepatotoxicity. The role of hepatitis
C virus and the human immunodeficiency virus.
1998; 157: 1871-6.
Am J Respir Crit Care Med
207. Hwang SJ, Wu JC, Lee CH, Yen FS, Lu CL, Lin TP, Lee SD. A prospective
clinical study of isoniazid-rifampicin-pyrazinamide-induced liver injury in an area
endemic for hepatitis B. J Gastroenterol Hepatol 1997; 12: 87-91.
208. Wu JC, Lee SD, Yeh PF, Chan CY, Wang YJ, Huang YS, Tsai YT, Lee PY,
Ting LP, Lo KW. Isoniazid-rifampin-induced hepatitis in hepatitis C carriers.
Gastroenterology 1990; 98: 502-4.
209. Katz MD, Lor E. Acute interstitial nephritis associated with intermittent rifampin
use. Drug Intell Clin Pharm 1986; 20: 789-92.
210. Murray AN, Cassidy MJD, Templecamp C. Rapidly progressive glomerulonephritis
associated with rifampicin therapy for pulmonary tuberculosis.
1987; 46: 373-6.
Nephron
211. Walker-Renard P. Pruritus associated with intravenous rifampin. Am Rev Respir
Dis 1991; 144: 750-5.
212. Goldin HM, Schweitzer WJ, Bronson DM. Rifampin and exfoliative dermatitis.
(Correspondence). Ann Intern Med 1987; 107: 789.
213. Okano M, Kitano Y, Igarashi T. Toxic epidermal necrolysis due to rifampicin.
(Correspondence). J Am Acad Dermatol 1987; 17: 303-4.
214. Nyirenda K, Gill GV. Stevens-Johnson syndrome due to rifampicin.
(Correspondence). BMJ 1977; 2: 1189.
183